Clinical trial · Interventional
Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
NCT00955097CI-TRIAL-00012419Definity®terminatedPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): No funding for this study
Summary
Brief summary (as posted)
The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Tumors | Liver Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Definity® | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Definity Contrast Dye
- description
- During liver surgery Definity contrast dye will be administered follwed by an ultrasound to better detect liver tumors
- interventionNames
- Drug: Definity®
Primary outcomes (2)
- measure
- adverse events
- timeFrame
- 6-weeks post surgery
- measure
- identification of liver tumors
- timeFrame
- intra-operative
Secondary outcomes (1)
- measure
- improved ablation of liver tumors
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Undergoing a hepatic resection or hepatic ablation of pre-operative visualized liver tumor: 2. ≥ 18 years of age 3. If female of child-bearing potential, negative pregnancy test within 14 days prior to surgery 4. If subject is a sexually active male or a sexually active female of child-bearing potential, subject agrees to use a medically accepted form of contraception from the time of enrollment to completion of all follow-up study visits. 5. IRB-approved informed consent, signed by the subject or the subject's legally authorized representative. ≥ 18 years of age Exclusion Criteria: 1\. Not a suitable candidate for operation
References
Publications (0)
Data not yet available
No reference posted for this study.